Search

Your search keyword '"Xinfeng Qu"' showing total 47 results

Search Constraints

Start Over You searched for: Author "Xinfeng Qu" Remove constraint Author: "Xinfeng Qu"
47 results on '"Xinfeng Qu"'

Search Results

1. Feasibility and applicability of self-sampling based online cervical cancer screening: findings from the China online cervical cancer screening trial

2. Performance of P16INK4a immunocytochemical stain in facilitating cytology interpretation of HSIL for HPV-positive women aged 50 and above

Catalog

Books, media, physical & digital resources

3. Application an internet facilitation in a community-based cervical cancer screening project

4. A comparative analysis of cycle threshold (Ct) values from Cobas4800 and AmpFire HPV assay for triage of women with positive hrHPV results

5. Verification of the association of the cycle threshold (Ct) values from HPV testing on Cobas4800 with the histologic grades of cervical lesions using data from two population-based cervical cancer screening trials

6. Roles of extended human papillomavirus genotyping and multiple infections in early detection of cervical precancer and cancer and HPV vaccination

7. Safety and Acceptability of Three Ablation Treatments for High-Grade Cervical Precancer: Early Data From a Randomized Noninferiority Clinical Trial

8. Comparison of cycle threshold values of the Cobas HPV test and viral loads of the BMRT HPV test in cervical cancer screening

9. Effectiveness and feasibility of self-sampling for human papillomavirus testing for internet-based cervical cancer screening

10. Triaging HPV-positive, cytology-negative cervical cancer screening results with extended HPV genotyping and p16INK4a immunostaining in China

11. The prevalence and distribution of human papillomavirus among 10,867 Chinese Han women

12. Prevalence of Human Papillomavirus Among Chinese Han and Mongols Minority Women in Inner Mongolia, China: Reflected by Self-Collected Samples in CHIMUST

13. Evaluation of an isothermal amplification HPV detection assay for primary cervical cancer screening

14. Prevalence and sociodemographic correlates of anogenital Human Papillomavirus (HPV) carriage in a cross-sectional, multi-ethnic, community-based Asian male population.

15. The application of BMRT-HPV viral load to secondary screening strategies for cervical cancer.

16. The effectiveness of HPV viral load, reflected by Cobas 4800 HPV-Ct values for the triage of HPV-positive women in primary cervical cancer screening: Direct endocervical samples.

17. An Evaluation of the Cobas4800 HPV Test on Cervico-Vaginal Specimens in Liquid versus Solid Transport Media.

18. Performance of P16INK4a immunocytochemical stain in facilitating cytology interpretation of HSIL for HPV-positive women aged 50 and above.

19. The prevalence of HR-HPV infection based on self-sampling among women in China exhibited some unique epidemiologic features

20. Evaluation of p16INK4a immunocytology and human papillomavirus (HPV) genotyping triage after primary HPV cervical cancer screening on self-samples in China

21. Thermocoagulation versus cryotherapy for the treatment of cervical precancers

22. Evaluating the Performance of p16INK4a Immunocytochemistry in Cervical Cancer Screening

23. Prevalence of Human Papillomavirus Among Chinese Han and Mongols Minority Women in Inner Mongolia, China: Reflected by Self-Collected Samples in CHIMUST

24. Triaging HPV-positive, cytology-negative cervical cancer screening results with extended HPV genotyping and p16INK4a immunostaining in China

25. Evaluation of p16

26. Additional file 1 of Triaging HPV-positive, cytology-negative cervical cancer screening results with extended HPV genotyping and p16INK4a immunostaining in China

27. Clinical Efficacy and Safety of Fertility-Preservative PUSH Surgery for Diffuse Adenomyosis: Evidence from a 11-Year Prospective Investigation

28. The prevalence and distribution of human papillomavirus among 10,910 Chinese Han women

29. The effectiveness of human papillomavirus load, reflected by cycle threshold values, for the triage of HPV-positive self-samples in cervical cancer screening

30. Evaluating the Performance of p16

31. The application of BMRT-HPV viral load to secondary screening strategies for cervical cancer

32. Evaluation of Viral Load as a Triage Strategy With Primary High-Risk Human Papillomavirus Cervical Cancer Screening

33. Cervical Screening by Pap Test and Visual Inspection Enabling Same-Day Biopsy in Low-Resource, High-Risk Communities

34. Introduction of Intracapsular Rotary-cut Procedures (IRCP): A Modified Hysteromyomectomy Procedures Facilitating Fertility Preservation

35. Prevalence and sociodemographic correlates of anogenital Human Papillomavirus (HPV) carriage in a cross-sectional, multi-ethnic, community-based Asian male population

36. A Pilot Study to Evaluate an Internet-Based Cervical Cancer Screening Model Based on Self-Sampling

37. The effectiveness of HPV viral load, reflected by Cobas 4800 HPV-Ct values for the triage of HPV-positive women in primary cervical cancer screening: Direct endocervical samples

38. A New PCR-Based Mass Spectrometry System for High-Risk HPV, Part II

39. A Population-Based Clinical Trial Comparing Endocervical High-Risk HPV Testing Using Hybrid Capture 2 and Cervista From the SHENCCAST II Study

40. An Evaluation of the Cobas4800 HPV Test on Cervico-Vaginal Specimens in Liquid versus Solid Transport Media

41. Evaluation of a new solid media specimen transport card for high risk HPV detection and cervical cancer prevention

42. Evaluation of The Cervista HPV A9 group In Screening Patients for Cervical Cancer

43. The development and evaluation of a community based model for cervical cancer screening based on self-sampling

44. Human papillomavirus messenger RNA assay for cervical cancer screening: the Shenzhen Cervical Cancer Screening Trial I

45. The Chinese Cervical Cancer Prevention Study (CHICAPS) - The development of a new model for population based cervical cancer screening

46. A New PCR-Based Mass Spectrometry System for High-Risk HPV, Part II.

47. A Population-Based Clinical Trial Comparing Endocervical High-Risk HPV Testing Using Hybrid Capture 2 and Cervista From the SHENCCAST II Study.